Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study - Hochhaus, Andreas; Erben, Philipp; Reiter, Andreas (Journal of cancer research and clinical oncology, 2013)